BROADWOOD PARTNERS, L.P. - 27 Jan 2025 SCHEDULE 13D/A Report for Lineage Cell Therapeutics, Inc. Common Shares, no par value (LCTX)

Filing Manager
BROADWOOD PARTNERS, L.P.
Reporting Manager
NEAL C. BRADSHER
Security
Lineage Cell Therapeutics, Inc. Common Shares, no par value
Symbol
LCTX
Shares outstanding
236,115,743 shares
Disclosed Ownership
57,848,357 shares
Ownership
24.5%
Form type
SCHEDULE 13D/A
Filing time
28 Jan 2025, 20:07:41 UTC
Date of event
27 Jan 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BROADWOOD PARTNERS, L.P. 24.3% 57,455,729 0 57,455,729 /s/ Neal C. Bradsher* Neal C. Bradsher/President of Broadwood Capital, Inc. 0001278386
BROADWOOD CAPITAL, INC. 24.3% 57,455,729 0 57,455,729 /s/ Neal C. Bradsher* Neal C. Bradsher/President 0001278387
NEAL C. BRADSHER 24.5% 57,848,357 392,628 57,455,729 /s/ Neal C. Bradsher* Neal C. Bradsher 0001278388